In Part 3, Dr. Askew dissects quality control results from labs and how a client could better understand them.
Tree of Knowledge, Inc. (CSE: TOKI) has just gone public on the Canadian stock exchange and is aggressively pursuing the European market, including with a 5% acquisition of Macedonian producer NSYK Holdings
Lauren Pahnke makes the case for using CPC to isolate and extract CBD in a pharmaceutical setting.
There are many regulations, standards and guidelines for water testing, but here is what you need to know to keep your water safe.
Adelson makes his case for using patient input and more data to spur product innovation.
Steven Burton breaks down which certifications and standards cannabis companies should look at, both domestically and internationally.
The landmark decision to approve a drug derived from cannabis could reflect a major policy shift in the works on a federal level.
In Part 2, Dr. Askew takes a look at how potentially problematic laboratory cultures can affect test results.
This series of articles will help businesses better understand the laboratory jargon and their test results.
Christian Sweeney discusses four key aspects of processing cannabis: cultivation, extraction, analytics and biochemistry.